Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Kazem Rahimi, Deputy Director of The George Institute UK discusses a study in the UK regarding the impact of influenza vaccination for patients with heart-failure.

Patients with heart disease are substantially more at risk of admission to hospital and a proportion of those admissions are thought to be related to influenza infection or at least triggered by an influenza infection.  

Listen to find out more about Professor Rahimi's findings in this two minute video 

Similar stories

MitOX 2017 - 1st December

The Nuffield Department of Obstetrics & Gynaecology invites you to MitOX 2017 - an annual meeting with talks on mitochondrial genetics, physiology, neurosciences and cancer.

Cannabinoid biomedicine research programme launched

Oxford University and Kingsley Capital Partners have launched a new research programme to investigate the role of cannabinoids in biology and medicine.

Multi-centre collaboration awarded NIH grant funding for endometriosis study

Funding for a five-year, $3 million multi-centre collaborative study into the causes of endometriosis has been awarded by the US National Institutes of Health to Oxford Professors Krina Zondervan and Christian Becker, Directors of the Oxford Endometriosis CaRe Centre.

Disadvantaged women at greater risk of heart disease than men

Women from low socioeconomic backgrounds are 25 per cent more likely to suffer a heart attack than disadvantaged men, a major new study has found.

In the Aftermath of the National Children’s Study

Is Large Birth Cohort Data Still a Priority?

INTERGROWTH-21st team receives grant to improve infant health and development

A global research project that aims to improve the health, nutritional status and development of preterm infants has been awarded a $2.8 million grant from the Family Larsson-Rosenquist Foundation (FLRF).